Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy.

about

Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches.

P2860

Q36295510-0C201395-998A-4DBF-8F5B-69D90B67B1AA Q38239833-E809899E-A227-4CFC-B8E0-1A9E419F055D

P2860

Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy.

Item

http://www.wikidata.org/entity/Q38099963

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Prognostic factors and outcome ...... treated by multimodal therapy.

@en

type

Item

label

Prognostic factors and outcome ...... treated by multimodal therapy.

@en

prefLabel

Prognostic factors and outcome ...... treated by multimodal therapy.

@en

P1476

Prognostic factors and outcome ...... treated by multimodal therapy.

@en

P2093

Catherine Lhommé

http://www.w3.org/2001/XMLSchema#string

Gabriel G Malouf

http://www.w3.org/2001/XMLSchema#string

Patricia Pautier

http://www.w3.org/2001/XMLSchema#string

Philippe Morice

http://www.w3.org/2001/XMLSchema#string

Pierre Duvillard

http://www.w3.org/2001/XMLSchema#string

P2860

The management of patients with uterine sarcoma: a debated clinical challenge

Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.

A multi-institutional review of outcomes of endometrial stromal sarcoma.

Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.

Endometrial stromal sarcoma: a population-based analysis

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.

Treatment of uterine sarcomas.

The role of adjuvant radiation in uterine sarcomas.

P304

57-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJGO.2013.01.025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Christine Haie-Meder

P577

2013-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23597861

http://www.w3.org/2001/XMLSchema#string

Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy.

about

P2860

P2860

Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698